fig4
Figure 4. Flow chart for decision making in patients with Fabry disease and gastrointestinal manifestations. *Late-onset Fabry patients do not show GL-3 accumulation in the gastrointestinal system. In these patients, GI symptoms must be attributable to gastric comorbidities.
